Valeant Pharmaceuticals chief executive Joe Papa says the drugmaker, which also owns Waterford’s Bausch + Lomb, has slimmed down enough for now and will focus on generating cash from its remaining businesses as it pays down a mountain of debt.

125 new jobs are on the way for Waterford.

A pharmaceutical company which is in the process of implementing 200 job losses has announced plans to upgrade its production systems with support from the IDA.

More than 1,100 workers at the southeast’s largest private sector employer are expected to vote early next week on a series of cuts which would see almost 200 of their number losing their jobs.